TruTag Technologies, Inc.

TruTag Technologies, Inc. provides innovative authentication solutions that utilize invisible, edible barcodes to prevent counterfeiting in pharmaceuticals, food products, and electronic components. Founded in 2010 and headquartered in Emeryville, US, TruTag Technologies specializes in advanced authentication solutions. The company has undergone a strategic pivot to focus on embedding its invisible barcodes, known as TruTags®, in various products.

The firm has raised USD 14. 69 mn in its latest funding round, Series D, which is equal to the total amount raised. As of November 2021, the company has completed a total of 5 investment deals. Barry McDonogh serves as the CEO.

TruTag Technologies specializes in advanced authentication solutions designed to combat counterfeit goods across various industries. The company's core offering revolves around TruTags®, which are invisible, edible barcodes that can be embedded in pharmaceuticals, food products, and electronic components. These TruTags are constructed from a nanoporous 3D honeycomb structure, making them virtually impossible to replicate. Their technology enables real-time data capture for product authentication and patient compliance, addressing critical issues such as counterfeit medications, food fraud, and the integrity of electronic components.

TruTag's solutions cater to a diverse clientele, including pharmaceutical manufacturers, food producers, and battery manufacturers, with applications in markets such as the United States, Australia, and China. By leveraging partnerships with companies like Colorcon, TruTag enhances the traceability of its products, ensuring a transparent supply chain from production to consumer. TruTag Technologies generates revenue through strategic partnerships and the sale of its proprietary authentication solutions. The company collaborates with clients to integrate TruTags into their products, enabling robust traceability and verification processes.

Transactions typically occur on a B2B basis, where manufacturers purchase TruTags and associated services as part of their production processes. These partnerships may involve contracts that outline pricing structures for product implementation, ongoing support, and data management services. TruTag’s flagship products, including its on-dose authentication platform, contribute to various applications in pharmaceutical and food industries, wherein customers benefit from enhanced product safety and compliance measures. The revenue model includes one-time implementation fees, along with potential recurring fees for data analytics and support services, tailored to the needs of each client and their specific market demands.

TruTag Technologies plans to leverage its recent Series D funding of USD 14. 69 mn to enhance its product offerings and expand into new geographic markets. The company is focused on developing new applications for its TruTags® and aims to launch these innovations by the end of 2022. Additionally, TruTag is targeting expansion into markets such as Europe and Southeast Asia to increase its global presence and accessibility.

Through these initiatives, the firm aims to solidify its market position and enhance its capabilities in product authentication.